Orca Bio is a late-stage biotechnology company developing high-precision allogeneic cell therapies for the treatment of blood cancers and autoimmune diseases.
The company uses a single-cell precision manufacturing platform to create personalized cell therapy products intended to replace a patient’s diseased blood and immune system with a healthy one.
Leadership & Board
Current Number of Employees336
Current LinkedIn Followers23,615
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$250M
Total Amount Raised$250M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$250M
Latest Funding Amount$250M
Latest Funding RoundSeries F
Latest Funding RoundSeries F
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks2
Articles Published on TipRanks
2
LinkedIn Trend+0.39% followers
LinkedIn Trend
+0.39% followers
Workforce Trend+2.8% employees
Workforce Trend
+2.8% employees
Orca Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Orca Bio had 336 employees as of June 8, 2026. The number of employees increased by 9 (2.75%) week-over-week.
336Latest Employee Count
9(2.75%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Orca Bio had 23,615 followers as of June 8, 2026. The number of followers increased by 92 (0.39%) week-over-week.
23,615Latest Followers Count
92(0.39%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Jan 09, 2026
Series F
$250.00M
―
Investors
Series F
